Phylaxia 1912 Holding to report 2011 losses of HUF 5.16 bln to shareholders
Hungarian veterinary-drug company Phylaxia 1912 Holding announced on Monday evening that it will report consolidated 2011 losses of HUF 5.16 billion at the company's March 20 AGM.
The company reported net losses of HUF 645 million in the first half of the year.
Phylaxia said that it had consolidated total assets of HUF 3.64 billion at the end of 2011. The figure is sharply down from total assets of HUF 7.88 billion on June 30, 2011.
Unconsolidated net losses totaled HUF 4.94 billion last year and unconsolidated total assets stood at HUF 2.62 billion at the end of 2011.
The company noted that the data is unaudited and therefore subject to change.
Phylaxia is a B-category issuer at the Budapest Stock Exchange.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.